Developer docs
API playgroundTry for free, no card

Search company profiles

EyeCheq

Full company profile

uuid00084mi

Namestring
EyeCheq
Websiteurl
eyecheq.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

EyeCheq is a Miami-based, privately held healthcare technology company founded in 2021 that builds AI-powered, self-guided retinal screening kiosks for point-of-care detection of diabetic retinopathy and other eye diseases. The kiosks perform a 5-minute retinal scan using computer vision and are designed to be deployed in community health centers and tribal healthcare systems, specifically targeting rural and Native American communities that face limited access to specialist ophthalmologists — what the company describes as eye-care deserts. The product positions the retina as a window to broader systemic health, with value-prop messaging around macular degeneration and glaucoma in addition to diabetic retinopathy, supported by an interactive live US disease map on the company website that tracks new diabetes diagnoses and preventable vision loss events in near real-time.

Short descriptiontext

EyeCheq provides AI-powered retinal screening kiosks that detect diabetic retinopathy in 5 minutes at point of care, serving community health centers and tribal healthcare systems in rural and underserved US communities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
retinal screening platform, diabetic retinopathy screening, AI vision diagnostics, point-of-care kiosk, community health screening
Industry3 codes
PRIMARYHLALAGAL
Ophthalmology & Vision Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKAKAA
Comprehensive Eye Exams & Vision Care
SECONDARYHLAHAJAC
Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
NAICS code1 code
  • Offices of Optometrists621320
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diabetic Retinopathy Screening
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Vision Screening Services
TypeSubscription Recurring
Description

AI-powered retinal screening services delivered through kiosk deployments in community health centers and tribal healthcare systems for diabetic retinopathy detection and prevention of diabetes-related blindness.

prweb.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Technology or R&D
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

EyeCheq deploys AI-powered, self-guided retinal screening kiosks at the point of care in community health centers and tribal healthcare systems. Each kiosk delivers a 5-minute retinal scan analyzed by computer vision to detect diabetic retinopathy and other eye conditions in asymptomatic, at-risk patients. The platform also publishes a live map of diabetes diagnoses and preventable vision loss events across the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 90% of diabetes-related blindness is preventable with early retinal screening
+2 more records
Product overview1 text field

EyeCheq offers a single unified product: an AI-powered vision screening kiosk that provides 5-minute retinal screening at the point of care. The kiosk is designed for deployment in underserved areas including rural communities and Native American tribal health systems, addressing eye-care deserts through self-guided screening technology. The platform includes a live mapping feature tracking diabetes diagnoses and preventable vision loss across the United States.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-07
Description

Strategic alliance to deploy AI-powered vision screening kiosks in rural and Native American communities to address eye-care deserts. The partnership focuses on increasing access to eye care in underserved areas to prevent blindness caused by diabetes. Deployment utilizes self-guided kiosks in community health centers and tribal healthcare systems.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Digital Diagnostics developed IDx-DR, the first FDA-cleared autonomous AI system for diabetic retinopathy detection at the point of care. It is the most direct comparator to EyeCheq's autonomous AI retinal screening kiosk model, targeting similar primary-care and underserved settings with specialist-free screening.

TypeDirect peer
Description

IRIS is a tele-retinal imaging platform that deploys retinal cameras in primary care and endocrinology practices, with remote specialists reading images to detect diabetic retinopathy. It overlaps directly with EyeCheq's screening-at-point-of-care value proposition and primary-care-first go-to-market.

TypeDirect peer
Description

AEYE Health builds AI-based retinal screening solutions for diabetic retinopathy and other ocular conditions, with an FDA clearance pathway and focus on point-of-care use. Its autonomous screening approach and clinical focus closely parallel EyeCheq's AI-powered retinal kiosk model.

TypeDirect peer
Description

Eyenuk develops EyeArt, an FDA-cleared AI system for autonomous detection of diabetic retinopathy, deployed in primary care and endocrinology settings. It is a direct functional peer to EyeCheq's autonomous AI retinal screening offering.

TypeDirect peer
Description

Remidio manufactures portable, AI-enabled retinal imaging devices for use in primary care, community health, and resource-limited settings. Its portable screening hardware and underserved-market focus make it highly comparable to EyeCheq's kiosk-based, community-deployment model.

TypeDirect peer
Description

Optomed produces handheld and desktop fundus cameras paired with AI screening software for diabetic retinopathy and other retinal diseases, targeting primary care and screening programs. Its combination of low-cost imaging hardware and AI analytics overlaps directly with EyeCheq's deployment strategy.

TypeBroad incumbent
Description

Topcon Healthcare is a large, established ophthalmic device and healthcare-IT vendor offering fundus cameras, screening workflows, and population-health tools used by optometrists and health systems. It competes in the same retinal-screening category as EyeCheq but with a much broader portfolio and traditional clinical-channel focus.

TypeBroad incumbent
Description

ZEISS Medical Technology supplies ophthalmic diagnostic devices, imaging platforms, and screening solutions used in clinical eye care globally. While it operates at much greater scale across the ophthalmic value chain, its retinal imaging and screening offerings overlap with the same clinical workflows EyeCheq targets.

TypeEmerging player
Description

RetinaLyze offers cloud-based AI retinal image analysis for diabetic retinopathy and other eye conditions, often integrated with partner fundus cameras. Its narrower scope and earlier commercialization stage make it a partially-overlapping peer to EyeCheq's screening platform.

TypeRegional player
Description

Orbis operates Cybersight, a tele-ophthalmology platform that connects eye care providers in low- and middle-income countries with specialists for screening, diagnosis, and training. Its global health and underserved-population mission parallels EyeCheq's community/tribal deployment focus, although it operates internationally rather than US-domestically.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EyeCheq

Diabetic Retinopathy Screeningeyecheq.com

EyeCheq provides AI-powered retinal screening kiosks that detect diabetic retinopathy in 5 minutes at point of care, serving community health centers and tribal healthcare systems in rural and underserved US communities.

What EyeCheq does

EyeCheq is a Miami-based, privately held healthcare technology company founded in 2021 that builds AI-powered, self-guided retinal screening kiosks for point-of-care detection of diabetic retinopathy and other eye diseases. The kiosks perform a 5-minute retinal scan using computer vision and are designed to be deployed in community health centers and tribal healthcare systems, specifically targeting rural and Native American communities that face limited access to specialist ophthalmologists — what the company describes as eye-care deserts. The product positions the retina as a window to broader systemic health, with value-prop messaging around macular degeneration and glaucoma in addition to diabetic retinopathy, supported by an interactive live US disease map on the company website that tracks new diabetes diagnoses and preventable vision loss events in near real-time.

EyeCheq firmographics

Firmographics
Name
EyeCheq
Website
https://eyecheq.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
EyeCheq provides AI-powered retinal screening kiosks that detect diabetic retinopathy in 5 minutes at point of care, serving community health centers and tribal healthcare systems in rural and underserved US communities.
Ownership category
akta.pro rank

EyeCheq industry classification

Industry
Product category
Diabetic Retinopathy Screening
NAICS
Offices of Optometrists (621320)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLALAGAL
Ophthalmology & Vision Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKAKAA
Comprehensive Eye Exams & Vision Care
SECONDARYHLAHAJAC
Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

  • Retinal screening platform
  • Diabetic retinopathy screening
  • AI vision diagnostics
  • Point-of-care kiosk
  • Community health screening

Where EyeCheq is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Markets served

EyeCheq business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D

Revenue model

  1. Vision Screening Services: AI-powered retinal screening services delivered through kiosk deployments in community health centers and tribal healthcare systems for diabetic retinopathy detection and prevention of diabetes-related blindness.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

EyeCheq product offering

Product offering

Core offering

EyeCheq deploys AI-powered, self-guided retinal screening kiosks at the point of care in community health centers and tribal healthcare systems. Each kiosk delivers a 5-minute retinal scan analyzed by computer vision to detect diabetic retinopathy and other eye conditions in asymptomatic, at-risk patients. The platform also publishes a live map of diabetes diagnoses and preventable vision loss events across the United States.

Product overview

EyeCheq offers a single unified product: an AI-powered vision screening kiosk that provides 5-minute retinal screening at the point of care. The kiosk is designed for deployment in underserved areas including rural communities and Native American tribal health systems, addressing eye-care deserts through self-guided screening technology. The platform includes a live mapping feature tracking diabetes diagnoses and preventable vision loss across the United States.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 90% of diabetes-related blindness is preventable with early retinal screening
  • +2 more outcomes

Companies that use EyeCheq

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

EyeCheq technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

EyeCheq partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CoPeace HealthcoreStrategic or Co-development Partner · 7 November 2025Strategic alliance to deploy AI-powered vision screening kiosks in rural and Native American communities to address eye-care deserts. The partnership focuses on increasing access to eye care in underserved areas to prevent blindness caused by diabetes. Deployment utilizes self-guided kiosks in community health centers and tribal healthcare systems.

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

EyeCheq competitors and assessment

Company assessment

Direct peers

  • Digital Diagnostics: Digital Diagnostics developed IDx-DR, the first FDA-cleared autonomous AI system for diabetic retinopathy detection at the point of care. It is the most direct comparator to EyeCheq's autonomous AI retinal screening kiosk model, targeting similar primary-care and underserved settings with specialist-free screening.
  • IRIS (Intelligent Retinal Imaging Systems): IRIS is a tele-retinal imaging platform that deploys retinal cameras in primary care and endocrinology practices, with remote specialists reading images to detect diabetic retinopathy. It overlaps directly with EyeCheq's screening-at-point-of-care value proposition and primary-care-first go-to-market.
  • AEYE Health: AEYE Health builds AI-based retinal screening solutions for diabetic retinopathy and other ocular conditions, with an FDA clearance pathway and focus on point-of-care use. Its autonomous screening approach and clinical focus closely parallel EyeCheq's AI-powered retinal kiosk model.
  • Eyenuk: Eyenuk develops EyeArt, an FDA-cleared AI system for autonomous detection of diabetic retinopathy, deployed in primary care and endocrinology settings. It is a direct functional peer to EyeCheq's autonomous AI retinal screening offering.
  • Remidio: Remidio manufactures portable, AI-enabled retinal imaging devices for use in primary care, community health, and resource-limited settings. Its portable screening hardware and underserved-market focus make it highly comparable to EyeCheq's kiosk-based, community-deployment model.
  • Optomed: Optomed produces handheld and desktop fundus cameras paired with AI screening software for diabetic retinopathy and other retinal diseases, targeting primary care and screening programs. Its combination of low-cost imaging hardware and AI analytics overlaps directly with EyeCheq's deployment strategy.

Broad incumbents

  • Topcon Healthcare: Topcon Healthcare is a large, established ophthalmic device and healthcare-IT vendor offering fundus cameras, screening workflows, and population-health tools used by optometrists and health systems. It competes in the same retinal-screening category as EyeCheq but with a much broader portfolio and traditional clinical-channel focus.
  • ZEISS Medical Technology: ZEISS Medical Technology supplies ophthalmic diagnostic devices, imaging platforms, and screening solutions used in clinical eye care globally. While it operates at much greater scale across the ophthalmic value chain, its retinal imaging and screening offerings overlap with the same clinical workflows EyeCheq targets.

Emerging players

  • RetinaLyze: RetinaLyze offers cloud-based AI retinal image analysis for diabetic retinopathy and other eye conditions, often integrated with partner fundus cameras. Its narrower scope and earlier commercialization stage make it a partially-overlapping peer to EyeCheq's screening platform.

Regional players

  • Orbis International (Cybersight): Orbis operates Cybersight, a tele-ophthalmology platform that connects eye care providers in low- and middle-income countries with specialists for screening, diagnosis, and training. Its global health and underserved-population mission parallels EyeCheq's community/tribal deployment focus, although it operates internationally rather than US-domestically.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks2 records

Key highlights6 records

Customer concentration

EyeCheq social profiles

Digital presence

EyeCheq financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EyeCheq leadership team

Management profile

Number of profiles

EyeCheq funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EyeCheq M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EyeCheq

What does EyeCheq do?

EyeCheq deploys AI-powered, self-guided retinal screening kiosks at the point of care in community health centers and tribal healthcare systems. Each kiosk delivers a 5-minute retinal scan analyzed by computer vision to detect diabetic retinopathy and other eye conditions in asymptomatic, at-risk patients. The platform also publishes a live map of diabetes diagnoses and preventable vision loss events across the United States.

Is EyeCheq a public or private company?

EyeCheq is a private company. It is classified as unknown and is currently operating.

When was EyeCheq founded?

EyeCheq was founded in 2021. It employs 1 to 10 people.

Where is EyeCheq based?

EyeCheq is headquartered in Miami, United States, in the North America region.

How does EyeCheq make money?

One revenue line is on record: vision Screening Services.

Who are EyeCheq's main competitors?

Direct peers on record are Digital Diagnostics, IRIS (Intelligent Retinal Imaging Systems), AEYE Health, Eyenuk, Remidio and Optomed. Broad incumbents are Topcon Healthcare and ZEISS Medical Technology. RetinaLyze is listed as an emerging player. Orbis International (Cybersight) is listed as a regional player.

Does EyeCheq have an API?

No public API is recorded for EyeCheq.

What industry is EyeCheq in?

EyeCheq's product category is Diabetic Retinopathy Screening. Its primary akta.pro industry code is HLALAGAL, Ophthalmology & Vision Telemedicine Platforms, with a secondary code of HLAKAKAA, Comprehensive Eye Exams & Vision Care. Its NAICS code is 621320 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooChristopher Grant Named One of the Top 5 Entrepreneurs of 2026 for a Healthcare Innovation Philosophy Inspired by the Science and Art of MagicChristopher Grant, Chief Commercial Officer of EyeCheq, has been named one of the Top 5 Entrepreneurs of 2026 for his 'Effect First Thinking' healthcare innovation philosophy. This approach prioritizes defining patient outcomes and experiences before selecting technology, a framework derived from principles of magic and psychology. The recognition highlights EyeCheq's deployment of self-service retinal imaging technology designed to improve access to diabetic retinopathy screening.FinancialContent Business PageChristopher Grant Named One of the Top 5 Entrepreneurs of 2026 for a Healthcare Innovation Philosophy Inspired by the Science and Art of MagicChristopher Grant, Chief Commercial Officer of EyeCheq, has been named one of the Top 5 Entrepreneurs of 2026 for his healthcare innovation philosophy rooted in the principles of magic and psychology. His 'Effect First Thinking' framework emphasizes defining patient outcomes before selecting technologies, a strategy that helped EyeCheq secure national contracts with major laboratory networks and retailers for diabetic retinopathy screening.TradingViewRevenio Group’s iCare and EyeCheq announce strategic partnership and minority investmentiCare, a division of Finnish eye care company Revenio Group, has entered into a strategic partnership and minority investment with U.S.-based EyeCheq to expand point-of-care eye screening through EyeCheq stations in the United States. The EyeCheq stations integrate iCare's DRSplus fundus imaging device and provide automated screening for diabetic retinopathy, glaucoma, and age-related macular degeneration, with imaging results reviewed by a network of licensed eye care physicians. In connection with the investment, EyeCheq appointed John Floyd, VP of U.S. Sales, to its Board of Directors to align governance as the two organizations accelerate joint commercial initiatives.PrwebEyeCheq and CoPeace Health Launch Alliance to Deploy AI-Powered Vision Screening in America's "Eye-Care Deserts"EyeCheq and CoPeace Health PBC announced a strategic partnership to deploy AI-powered, self-service vision screening kiosks in rural and Native American communities across the United States. The kiosks will provide diabetic retinopathy screenings and basic eye care to address the critical lack of access in America's "eye-care deserts." This initiative aims to bridge healthcare gaps by bringing sight-saving diagnostics directly to underserved populations through community health centers, tribal health systems, and rural clinics.NottinghamspirkAI powered by NSThe article is a promotional piece for Nottingham Spirk, highlighting its capabilities in developing AI-powered firmware and hardware solutions. It details two specific case studies: one involving EY-Nottingham Spirk assisting a major manufacturer with IP portfolio analysis, and another featuring EyeCheq's autonomous eye screening kiosk developed in partnership with the firm.PR NewswireEyeCheq Bolsters its Executive Team Ahead of LaunchEyeCheq, a Miami-based developer of autonomous eye screening technology, announced the expansion of its leadership team with the appointment of Dr. Ruwan Silva as Chief Medical Officer and Christopher Grant as Executive Vice President of Operations. Dr. Silva brings ophthalmology expertise from Harvard, Cambridge, and Stanford universities, while Mr. Grant joins from Quest Diagnostics where he led diabetic retinal screening programs across 2,200 clinics. The company, which positions itself as the world's first fully automated eye health platform, stated the appointments are designed to strengthen its scientific and operational expertise ahead of launching its autonomous eye screening solution.Daily Medical NewsQ&A: Fully automated eye screening platform addresses unmet eye care needsEyeCheq, a Miami-based health tech company, developed a fully automated eye screening platform for primary care and retail settings. The device screens for anterior and posterior segment pathology, with results sent to patients and providers. The first rollout is expected in the next few months.Eyes On EyecareEyeCheq adds new exec in mission to target early diagnosis of blinding diseasesEyeCheq appointed Jai G. Parekh as executive vice president and chief innovation officer. The tele-ophthalmology platform screens for blinding diseases like diabetic retinopathy and glaucoma, and Parekh will focus on early detection in asymptomatic patients. The company also plans to expand into anterior segment eye care.